Nurix’s $120m Venture Round Will Bring Two Protein-Modulating Therapies To Clinic

 
• By Joseph Haas
Funding Economy FInancial Collection Fund Concept
A $120m financing should enable Nurix to get two programs into clinical development

More from Financing

More from Business